Lionsgate Studios Corp Common Shares vs Synopsys, Inc. — how do they compare? Lionsgate Studios Corp Common Shares trades at $10.89 (market cap $3.24B), while Synopsys, Inc. trades at $474.22 (market cap $91.97B). The key difference: Synopsys, Inc. is far larger — about 28.4× Lionsgate Studios Corp Common Shares's market cap, and Synopsys, Inc. is trading nearer its 52-week high, Lionsgate Studios Corp Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Lionsgate Studios Corp Common Shares for 0 Days and Synopsys, Inc. for 72 Days on average.
| LION | SNPS | |
|---|---|---|
Market Cap | $3.24B | $91.97B |
Volume | 3,214,595 | 3,203,530 |
Sector | Technology | Technology |
52-Week High | $16.40 | $534.56 |
52-Week Low | $5.91 | $367.70 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $6.75B | $99.21B |
Signals from Pluang's Aura AI — not financial advice
LION trades at $11.12, up 0.36% on the day, with a market cap of approximately $1.3 billion. The stock shows mixed signals: strong analyst support (87.5% buy rating) and a consensus price target of $16.80 suggest upside, but negative net income and shareholder equity highlight financial strain. Recent Q1 2027 earnings beat estimates with EPS of $0.37, yet the company remains unprofitable with a net loss of $128.5 million in 2025. Takeover interest from firms like Bolloré adds speculative appeal.
The outlook hinges on operational turnaround and potential M&A. Revenue growth from hit films like 'Michael' and a valuable content library offer catalysts, but high debt ($3.65B total) and consistent losses pose significant risks. Investors should weigh the 51% upside to price targets against fundamental weaknesses and industry volatility.
Synopsys (SNPS) trades at $494.51, down 1.59% on the day, but maintains a strong bullish technical trend with recent price action supported by positive investor sentiment. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.91 exceeding the $3.67 estimate. Recent partnerships with OpenAI and Amazon Web Services, including a $1 billion deal, have driven optimism and a 13% stock surge, highlighting its strategic positioning in AI-driven chip design.
The outlook for SNPS is positive, supported by robust analyst consensus, with 28 of 30 analysts rating it a Buy and a consensus price target of $575.93 implying significant upside. Key risks include high valuation multiples, such as a P/E of 86.3, and integration challenges from the Ansys acquisition. Revenue growth is projected to accelerate, with 2026 guidance surpassing expectations, though margin compression remains a watch point.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Lionsgate Studios Corp. is a standalone content company that develops, finances, produces, and distributes motion pictures and television series, licensing its content to theaters, streaming platforms, television networks, and home entertainment channels.
Read more on LION →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →